The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117087632 11708763 2 F 20100406 20160822 20151107 20160822 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-15323611 BRISTOL MYERS SQUIBB 31.00 YR F Y 0.00000 20160822 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117087632 11708763 1 PS ATAZANAVIR SULFATE ATAZANAVIR SULFATE 1 Oral UNK 21567
117087632 11708763 2 SS SUSTIVA EFAVIRENZ 1 Oral COURSE:1 Y 0 CAPSULE
117087632 11708763 3 C ZIAGEN ABACAVIR SULFATE 1 Oral UNK 0
117087632 11708763 4 C ZIAGEN ABACAVIR SULFATE 1 Oral UNK 0
117087632 11708763 5 C NORVIR RITONAVIR 1 Oral UNK 0
117087632 11708763 6 C VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 Oral UNK 0
117087632 11708763 7 C RETROVIR ZIDOVUDINE 1 Intravenous (not otherwise specified) UNK U 0
117087632 11708763 8 C MICARDIS PLUS HYDROCHLOROTHIAZIDETELMISARTAN 1 Unknown UNK U 0
117087632 11708763 9 C SPASFON PHLOROGLUCINOL 1 Unknown UNK U 0
117087632 11708763 10 C CELESTENE BETAMETHASONE 1 Unknown UNK U 0
117087632 11708763 11 C CLAMOXYL AMOXICILLINCLAVULANIC ACID 1 Unknown UNK U 0
117087632 11708763 12 C LOXEN NICARDIPINE HYDROCHLORIDE 1 Unknown UNK U 0
117087632 11708763 13 C VITAMIN D CHOLECALCIFEROL 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117087632 11708763 1 Antiretroviral therapy
117087632 11708763 2 Antiretroviral therapy
117087632 11708763 3 Antiretroviral therapy
117087632 11708763 5 Antiretroviral therapy
117087632 11708763 6 Antiretroviral therapy
117087632 11708763 7 Antiretroviral therapy
117087632 11708763 8 Product used for unknown indication
117087632 11708763 9 Product used for unknown indication
117087632 11708763 10 Product used for unknown indication
117087632 11708763 11 Product used for unknown indication
117087632 11708763 12 Product used for unknown indication
117087632 11708763 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117087632 11708763 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117087632 11708763 Albuminuria
117087632 11708763 Anaemia
117087632 11708763 Blood alkaline phosphatase increased
117087632 11708763 Blood urea decreased
117087632 11708763 Live birth
117087632 11708763 Maternal exposure during pregnancy
117087632 11708763 Premature delivery
117087632 11708763 Proteinuria
117087632 11708763 Uterine disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117087632 11708763 1 20091119 0
117087632 11708763 2 20091001 0
117087632 11708763 4 20091119 0
117087632 11708763 5 20091119 0
117087632 11708763 6 20050101 0
117087632 11708763 7 20100406 20100406 0